A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.

L G Feun; N Savaraj; S Hung; R Reddy; L Jeffers; P Benedetto; A S Livingstone; B Ardalan; J U Levi; T Parker

doi:10.1097/00000421-199410000-00007

A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.

Identifier:nobleid.org/w1/20260515/EDBBCB76

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EDBBCB76.svg?ark=w1%2F20260515%2FEDBBCB76)](https://nobleid.org/work/w1/20260515/EDBBCB76)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.

Identifier:nobleid.org/w1/20260515/EDBBCB76

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EDBBCB76.svg?ark=w1%2F20260515%2FEDBBCB76)](https://nobleid.org/work/w1/20260515/EDBBCB76)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work